ArticleOTA international : the open access journal of orthopaedic trauma2026
Osteoporosis medication initiation after proximal humerus fractures is low, but associated with decreased secondary fragility fracture risk.
Article in OTA international : the open access journal of orthopaedic trauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo 1) identify factors associated with osteoporosis medication (OPM) prescription after proximal humerus fractures and 2) evaluate rates of secondary osteoporotic fragility fracture (OFF) between patients treated with OPM vs those who were not.
methodsDesign: Retrospective cohort analysis. Setting: TriNetX Health Research Network. Patient Selection Criteria: Patients aged 60 years or older who sustained a proximal humerus fracture (PHF) (OTA/AO 11) between 2005 and 2025 were categorized into groups based on if they were or were not prescribed OPM within 1 year after a PHF. Outcome Measures and Comparisons: The primary outcome was prescription of OPM after PHF. Patient demographics were assessed between patients who were or were not prescribed OPM. Pairwise comparisons of proportions were performed using two-proportion Z-tests with Bonferroni correction. A matched cohort analysis was conducted to assess rates of secondary OFF after PHF. Measures of association models were used to determine odds ratios (OR).
resultsA total of 180,304 patients with PHFs were identified, with 6627 (3.7%) patients prescribed OPM after a PHF. Female patients were more likely to be prescribed OPM (84.6% vs 68.0%,
conclusionsOsteoporosis medications are not commonly initiated after geriatric PHFs. OPM initiation after PHF was associated with lower rates of secondary OFF and 1-year mortality. LEVEL OF EVIDENCE: Level III, Prognostic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.